NASDAQ:AVXL

Anavex Life Sciences Corp.

Stock

USD

Last Close

7.40

06/11 22:14

Market Cap

391.04M

Beta: 0.75

Volume Today

740.90K

Avg: 1.09M

PE Ratio

−8.31

PFCF: −16.52

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Sep '15	Sep '16	Sep '17	Sep '18	Sep '19	Sep '20	Sep '21	Sep '22	Sep '23
net income	-12.11M -	-14.74M 21.71%	-13.46M 8.66%	-17.45M 29.66%	-26.29M 50.66%	-26.28M 0.06%	-37.91M 44.25%	-47.98M 26.56%	-47.51M 0.99%
depreciation and amortization	995 -	1.25K 25.83%
deferred income tax	482.16K -	-58.14K 112.06%
stock based compensation	1.63M -	5.06M 209.81%	4.14M 18.31%	5.52M 33.40%	6.43M 16.56%	4.88M 24.16%	8.23M 68.78%	18.38M 123.28%	16.37M 10.93%
change in working capital	1.24M -	640.07K 48.29%	382.81K 40.19%	-646.00K 268.75%	1.30M 301.49%	116.52K 91.05%	-706.44K 706.30%	5.36M 858.85%	2.50M 53.27%
accounts receivables					-772.39K -	-2.21M 185.68%	-4.29M 94.30%	5.94M 238.64%	484K 91.86%
inventory					772.39K -	2.21M 185.68%	4.29M 94.30%	-5.94M 238.64%	-484K 91.86%
accounts payables		-151.40M -			683.80K -	465.72K 31.89%	750.73K 61.20%	-915.00K 221.88%	497K 154.32%
other working capital	1.24M -	152.04M 12,184.36%	382.81K 99.75%	-646.00K 268.75%	617.82K 195.64%	-349.20K 156.52%	-1.46M 317.28%	6.28M 530.69%	2.01M 68.00%
other non cash items	4.53M -	-145.57K 103.22%	-75.20K 48.34%		35.38K -				845K -
net cash provided by operating activities	-4.23M -	-9.24M 118.52%	-9.02M 2.38%	-12.58M 39.54%	-18.53M 47.25%	-21.29M 14.90%	-30.38M 42.73%	-24.24M 20.23%	-27.79M 14.63%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment	-88.14K -	-34.76K 60.57%
common stock issued	12.34M -	3.17M 74.34%	27.27M 760.97%	8.17M 70.03%	17.83M 118.16%	28.75M 61.25%	153.22M 432.86%	20.98M 86.30%	27.88M 32.84%
common stock repurchased
dividends paid
other financing activites				-101.13K -	-50K 50.56%	-403.76K 707.53%	23.64K 105.85%	303.31K 1,183.10%	1.78M 485.53%
net cash used provided by financing activities	12.26M -	3.13M 74.44%	27.27M 770.53%	8.07M 70.40%	17.78M 120.27%	28.35M 59.43%	153.24M 440.53%	21.29M 86.11%	29.65M 39.29%
effect of forex changes on cash
net change in cash	8.03M -	-6.10M 176.03%	18.25M 399.03%	-4.51M 124.71%	-745.01K 83.48%	7.06M 1,048.10%	122.86M 1,639.37%	-2.95M 102.40%	1.87M 163.26%
cash at beginning of period	7.26M -	15.29M 110.56%	9.19M 39.92%	27.44M 198.69%	22.93M 16.43%	22.19M 3.25%	29.25M 31.84%	152.11M 420.04%	149.16M 1.94%
cash at end of period	15.29M -	9.19M 39.92%	27.44M 198.69%	22.93M 16.43%	22.19M 3.25%	29.25M 31.84%	152.11M 420.04%	149.16M 1.94%	151.02M 1.25%
operating cash flow	-4.23M -	-9.24M 118.52%	-9.02M 2.38%	-12.58M 39.54%	-18.53M 47.25%	-21.29M 14.90%	-30.38M 42.73%	-24.24M 20.23%	-27.79M 14.63%
capital expenditure
free cash flow	-4.23M -	-9.24M 118.52%	-9.02M 2.38%	-12.58M 39.54%	-18.53M 47.25%	-21.29M 14.90%	-30.38M 42.73%	-24.24M 20.23%	-27.79M 14.63%

All numbers in USD (except ratios and percentages)